Finance Home - Business News - Popular - Sun Pharma's Q2 profit falls 59.7% on weak US sales

Sun Pharma's Q2 profit falls 59.7% on weak US sales


15 November 2017 04:03

border=1 height=1 Livemint Sun Pharma MD Dilip Shanghvi said a challenging US generic drug pricing environment coupled with investments in building the firm's global specialty business affected Q2 performance. Photo: Bloomberg. Mumbai: Sun Pharmaceutical Industries Ltd, India's... ---
.
Sun Pharma's Q2 profit falls 59.7% on weak US sales. This article is published at 15 November 2017 04:03 from Popular India Finance News, click on the read full article link below to see further details.


Read Full Article >>

Tags : Pharma, profit, falls, weak, sales


Share